Access and affordability of genetic services
The growing field of genomics raises questions of just and equitable access to health services for all. This issue is particularly challenging for developing countries where medicines are often more expensive than affordable by the ordinary citizen. We are witnessing major health inequities present throughout the world, an issue of continuing and pressing concern to leaders and the public.
Countries vary in the different health care provisions they offer the people. While some governments provide their citizens with health insurance, other countries have health insurance plans that can be purchased; yet many countries do not have any specific insurance coverage for their people, or at least coverage that is well-publicized. This page provides links to articles relating to access and affordability of health care, in addition to some documents regarding this topic.
These links are meant to serve both the lay public and policy makers, alike. The public is encouraged to read about the current disparities to be aware of the issues facing their communities. Policy makers may find these links useful for the planning of national health systems.
More information on the access and affordability of genetic services
- Ensuring equitable access to healthcare, Malaysia (2000)
- Health sector reform and equity: Brazil and Bolivia study cases (2001)
- Provision of genetic services in europe: current practices and issues (2001)
- Social inequality in the access to health care in Brazil (2002)
- Building on values: the future of health care in Canada (2002)
- Better Services, Better Health: the healthcare experiences of Black and minority ethnic disabled people (2002)
- Workshop on key issues in improving the accessibility to drugs in developing countries, World Bank (2003)
- International forum on common access to healthcare, quality and choice: Programme Statement (2003)